1-3 of 3
emax model
Close
Sort by
Journal Articles

Population Pharmacokinetics and Pharmacodynamics of AG-519, a Pyruvate Kinase Activator for the Treatment of Pyruvate Kinase Deficiency, in Human Healthy Volunteers

Kha Le, Marvin Cohen, Ann J Barbier, Elizabeth Merica, Charles Kung, Penelope A Kosinski, Scott Biller, Hua Yang
Journal: Blood
Blood (2016) 128 (22): 1263.
https://doi.org/10.1182/blood.V128.22.1263.1263
Published: 2016
Journal Articles

Results of the Phase 1 Trial of RG7112, a Small-Molecule MDM2 Antagonist, in Acute Leukemia

Michael Andreeff, MD, PhD, Kevin R. Kelly, MD, Karen Yee, MD, Sarit Assouline, Roger Strair, MD, PhD, Leslie Popplewell, MD, David Bowen, Giovanni Martinelli, MD, Mark W. Drummond, PhD, FRCPath, MB, CHB, Paresh Vyas, MD, Mark Kirschbaum, MD, Swaminathan Padmanabhan Iyer, MD, Kensuke Kojima, MD, PhD, David Geho, MD, Steven Blotner, PhD, Suzanne Cheng, PhD, Lyubomir Vassilev, PhD, Meichun Ding, PhD, Jianguo Zhi, PhD, Steven Middleton, PhD, Gwen Nichols, MD
Journal: Blood
Blood (2012) 120 (21): 675.
https://doi.org/10.1182/blood.V120.21.675.675
Published: 2012
Journal Articles

Changes in Mcl-1 and Bim Expression with Bortezomib and Melphalan Therapy for Multiple Myeloma.

Rakesh Popat, DipRCPath, Lyndsey Goff, PhD, Heather E. Oaekervee, MRCPath, Jamie D. Cavenagh, MD, Simon P. Joel, PhD
Journal: Blood
Blood (2005) 106 (11): 2481.
https://doi.org/10.1182/blood.V106.11.2481.2481
Published: 2005